New Jersey-based pharmaceutical Merck is undertaking 3 endeavors to fight Covid-19— including teaming up with nonprofit scientific research firm IAVI to develop a vaccine by lisettevoytko
with nonprofit scientific research firm IAVI to develop a vaccine, as companies around the world race to find an effective treatment against the virus.Photo by Arne Dedert/picture alliance via Getty ImagesMerck and IAVI’s potential coronavirus vaccine will use the same technology that is in Merck’s Ebola Zaire virus vaccine, known as recombinant vesicular stomatitis virus .
The rVSV vaccine uses a weakened strain of the virus to generate an immune response in the recipient., a company that focuses on vaccines and immune modulation therapies for infectious diseases and cancer and is working on a Covid-19 vaccine that uses a weakened strain of the measles virus.Ridgeback Biotherapeutics to create an oral antiviral treatment for the virus.
Clinical studies for the two vaccines are expected to start later in 2020, according to press statements.“COVID-19 is a global challenge and requires global solutions,” said Merck chairman and chief executive Kenneth C. Frazier . “Merck intends to make any vaccine or medicine we develop for this pandemic broadly accessible and affordable globally, and we are working now to accomplish this goal as quickly as possible.”One. That’s the number of doses Merck is ultimately aiming for in either Covid-19 vaccine. Roger Perlmutter, the head of Merck’s Research Laboratories,Key background
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Merck in collaboration to develop a coronavirus vaccine, with clinical trials to start later this yearMost experts agree that it could take between 12 to 18 months for a safe-to-use vaccine to be rolled out to the market.
Read more »
Dow Surges 600 Points As Investors Bet On A Coronavirus Vaccine BreakthroughStocks are racing higher on hopes for a new coronavirus vaccine.
Read more »
Dow futures jump more than 200 points on hopes of a coronavirus vaccineThe moves in futures followed a solid week for Wall Street that saw the 30-stock Dow post its best weekly performance since April.
Read more »
An 'unprecedented' effort to find a coronavirus vaccine has over 100 horses in the raceVaccines are perceived as key to ending the restraints on work and life that have decimated the global economy, and returning to some sense of normalcy.
Read more »
What to watch today: Dow to soar on coronavirus vaccine hopesDow futures surge Tuesday as investors bet on the economy reopening and a coronavirus vaccine breakthrough.
Read more »
Merck in collaboration to develop a coronavirus vaccine, with clinical trials to start later this yearMost experts agree that it could take between 12 to 18 months for a safe-to-use vaccine to be rolled out to the market.
Read more »